Mar 5, 2026 09:15AM
Feb 17, 2026 09:15AM
Feb 4, 2026 07:05AM
Jan 29, 2026 09:15AM
Jan 29, 2026 07:05AM
Jan 29, 2026 07:05AM
Dec 30, 2025 06:36AM Guggenheim Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
Dec 29, 2025 07:05AM
Dec 29, 2025 07:05AM
Dec 3, 2025 09:13AM
Dec 2, 2025 12:39PM
Dec 1, 2025 01:41PM
Nov 25, 2025 07:05AM
Nov 14, 2025 09:26AM Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Maison Solutions Inc. (NASDAQ: MSS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar
Nov 12, 2025 08:36AM
Nov 12, 2025 07:05AM
Nov 10, 2025 09:42AM
Nov 3, 2025 09:10AM
Nov 3, 2025 07:05AM
Oct 30, 2025 07:05AM
Oct 29, 2025 06:49AM Unicycive Therapeutics (UNCY) PT Raised to $22 at H.C. Wainwright
Oct 28, 2025 07:06AM
Oct 28, 2025 07:05AM
Oct 27, 2025 10:31AM
Oct 24, 2025 08:44AM
Oct 15, 2025 08:59AM
Oct 8, 2025 08:44AM
Oct 7, 2025 09:31AM Important Notice to Long-Term Shareholders of Humana Inc. (NYSE: HUM); Jasper Therapeutics, Inc. (NASDAQ: JSPR); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law
Sep 15, 2025 08:57AM
Sep 12, 2025 08:38AM
Sep 11, 2025 08:14AM
Aug 26, 2025 07:00AM
Aug 18, 2025 07:05AM
Aug 18, 2025 07:05AM
Aug 14, 2025 07:00AM Unicycive Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
Jul 24, 2025 08:02AM
Jul 24, 2025 08:00AM
Jul 8, 2025 08:31AM
Jul 8, 2025 08:30AM
Jul 7, 2025 07:00AM
Jul 6, 2025 10:00AM
Jul 1, 2025 09:34AM Unicycive (UNCY) Will Seek Type A Meeting to Resolve CRL Issues: Benchmark
Jun 30, 2025 07:05AM
Jun 30, 2025 07:05AM
Jun 17, 2025 07:01AM
Jun 17, 2025 07:00AM
Jun 11, 2025 06:38AM
Jun 10, 2025 06:02AM
Jun 10, 2025 06:00AM Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Jun 4, 2025 06:19AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All